Lemonade CFO Bixby sells $466k in shares

Lemonade (LMND) has restructured its reinsurance program, significantly reducing its quota share from approximately 55% to 20% and increasing its premium retention rate to 80%. This strategic shift prompted BMO Capital and Keefe, Bruyette & Woods to raise their price targets for LMND to $23 and $26 respectively, although both firms maintain an "Underperform" rating on the stock. Concurrently, Lemonade CFO Timothy E. Bixby sold 11,000 shares of common stock for $466,400 after exercising options.

Analysis

Lemonade, Inc. (LMND) has executed a significant strategic shift in its capital structure by reducing its quota share reinsurance from approximately 55% to 20%, effective July 1. This change materially increases the company's premium retention rate from 45% to 80%, indicating management's growing confidence in its underwriting and diversification capabilities. While this move exposes the company to greater risk, it also enhances its potential to improve margins. In response, both BMO Capital and Keefe, Bruyette & Woods raised their price targets to $23 and $26, respectively, citing the positive impact on earnings through lower expense ratios. However, both firms maintained their "Underperform" ratings, suggesting persistent concerns about the stock's valuation or long-term profitability despite the operational improvements. Concurrently, CFO Timothy E. Bixby sold 11,000 shares at an average price of around $42.40. This transaction was preceded by an options exercise to acquire the same number of shares at $23.69, a common practice for executives. The sale represents a small fraction of the CFO's total holdings of over 293,000 shares, but the sale price is notably almost double the updated analyst price targets.

Key Decisions for Investors

• Investors should weigh Lemonade's positive strategic shift towards higher premium retention, which could boost earnings, against the persistent 'Underperform' ratings from analysts who remain skeptical of the stock's valuation.
• The CFO's stock sale should be viewed in the context of an options exercise and his significant remaining stake; however, the large disparity between the sale price near $42.40 and the new analyst targets of $23-$26 warrants caution.
• Monitor Lemonade's loss and expense ratios in the upcoming quarters, as these metrics will be critical indicators of whether the increased risk from the new reinsurance structure is translating into improved profitability.